| Dione Duc, | |
|
777 Hemlock St # 104, Macon, GA 31201-2102 | |
| (478) 633-7550 | |
| (478) 633-3235 |
| Full Name | Dione Duc |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 777 Hemlock St # 104, Macon, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063049211 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 90702 (Georgia) | Primary |
| Entity Name | Cogent Healthcare Of Macon, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073564217 PECOS PAC ID: 9234104019 Enrollment ID: O20040826000927 |
News Archive
Researchers in the UK and United States have demonstrated the efficacy of one dose of either the Pfizer-BioNTech or Oxford-AstraZeneca vaccine against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a real-world community setting in the UK.
In its latest recommendations, the US Multi-Society Task Force on Colorectal Cancer Screening confirms that people at average risk should be screened beginning at age 50, and recommends colonoscopy and fecal immunochemical testing as the "first tier" screening tests for this group.
As a brain-damaged woman named Terri Schiavo lived her final days in 2005, her family's bitter feuding imparted a tragic lesson about the importance of specifying one's wishes for end-of-life medical treatment.
Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that it has initiated a Phase 1 clinical trial to study the safety and pharmacokinetics of XMT-1107 in patients with refractory advanced solid tumors. XMT-1107 is a novel anti-angiogenic fumagillin analog that employs Mersana's Fleximer platform. Mersana's XMT-1001, a conjugate of Fleximer and camptothecin, is currently completing a Phase 1 study.
NXT Nutritionals Holdings, Inc. ("NXT Nutritionals") developer and marketer of SUSTA™ Natural Sweetener, the great tasting, all-natural, healthier sweetener, today released a Letter to Shareholders from Michael McCarthy, president and Chief Executive Officer, providing investors and the investment community with its outlook for 2010.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dione Duc, 777 Hemlock St # 104, Macon, GA 31201-2102 Ph: (478) 633-7550 | Dione Duc, 777 Hemlock St # 104, Macon, GA 31201-2102 Ph: (478) 633-7550 |
News Archive
Researchers in the UK and United States have demonstrated the efficacy of one dose of either the Pfizer-BioNTech or Oxford-AstraZeneca vaccine against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a real-world community setting in the UK.
In its latest recommendations, the US Multi-Society Task Force on Colorectal Cancer Screening confirms that people at average risk should be screened beginning at age 50, and recommends colonoscopy and fecal immunochemical testing as the "first tier" screening tests for this group.
As a brain-damaged woman named Terri Schiavo lived her final days in 2005, her family's bitter feuding imparted a tragic lesson about the importance of specifying one's wishes for end-of-life medical treatment.
Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that it has initiated a Phase 1 clinical trial to study the safety and pharmacokinetics of XMT-1107 in patients with refractory advanced solid tumors. XMT-1107 is a novel anti-angiogenic fumagillin analog that employs Mersana's Fleximer platform. Mersana's XMT-1001, a conjugate of Fleximer and camptothecin, is currently completing a Phase 1 study.
NXT Nutritionals Holdings, Inc. ("NXT Nutritionals") developer and marketer of SUSTA™ Natural Sweetener, the great tasting, all-natural, healthier sweetener, today released a Letter to Shareholders from Michael McCarthy, president and Chief Executive Officer, providing investors and the investment community with its outlook for 2010.
› Verified 4 days ago
Dr. Anayo Umerah, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4050 Riverside Dr, Suite B, Macon, GA 31210 Phone: 478-746-2888 Fax: 478-746-2889 | |
Dr. Shuichi Nakai, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3780 Eisenhower Pkwy, Macon, GA 31206 Phone: 478-633-5550 Fax: 478-633-7287 | |
Sam G Amporful, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 721 Riverside Drive Lane, Macon, GA 31201 Phone: 478-259-3439 Fax: 478-254-2733 | |
Mrs. Stephanie Faye Bennett, Family Medicine Medicare: Medicare Enrolled Practice Location: 101 Gateway Drive, Macon, GA 31210 Phone: 478-210-1670 | |
Dr. Robert C Jones, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3200 Riverside Dr Ste B300, Macon, GA 31210 Phone: 478-405-5252 Fax: 478-477-8411 | |
Alice Rose House, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1550 College St, Suite A, Macon, GA 31207 Phone: 478-301-4111 Fax: 478-301-5812 |